Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design
<strong></strong>Due to high oxygen consumption, the brain is particularly vulnerable to oxidative stress, which is considered an important element in the etiopathogenesis of several mental disorders, including schizophrenia, depression and dependencies. Despite the fact that it is not e...
Main Authors: | Giovanni Ribaudo, Marco Bortoli, Chiara Pavan, Giuseppe Zagotto, Laura Orian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/8/714 |
Similar Items
-
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
by: Cecilia Muraro, et al.
Published: (2019-09-01) -
Dissociative states in borderline personality disorder and their relationships to psychotropic medication
by: Pec O, et al.
Published: (2018-11-01) -
Influence of psychotropic drugs on driving skils
by: Brigita Novak Šarotar, et al.
Published: (2013-02-01) -
Dreams, Sleep, and Psychotropic Drugs
by: Alain Nicolas, et al.
Published: (2020-11-01) -
Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England
by: Lamiece Hassan, et al.
Published: (2016-10-01)